EGFR and lung cancer: For example, miRNA-138-5p was significantly down-regulated in lung cancer cells resistant to gefitinib (a widely used small molecule EGFR tyrosine kinase inhibitor); re-expression of miRNA-138-5p was sufficient to sensitize gefitinib-resistant lung cancer cells to gefitinib [30].